LAMBERTINI, MATTEO
LAMBERTINI, MATTEO
100007 - Dipartimento di Medicina interna e specialità mediche
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
2019-01-01 de Azambuja, E.; Ponde, N.; Procter, M.; Rastogi, P.; Cecchini, R. S.; Lambertini, M.; Ballman, K.; Aspitia, A. M.; Zardavas, D.; Roca, L.; Gelber, R. D.; Piccart-Gebhart, M.; Suter, T.
A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients
2022-01-01 Condorelli, M.; Sens, M.; Goldrat, O.; Delbaere, A.; Racape, J.; Lambertini, M.; Demeestere, I.
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis
2023-01-01 Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate
2021-01-01 Poggio, F.; Tagliamento, M.; Ceppi, M.; Bruzzone, M.; Conte, B.; Fregatti, P.; Punie, K.; de Azambuja, E.; Del Mastro, L.; Lambertini, M.
Adherence to guidelines in requesting oncotype DX in a publicly funded health care system
2018-01-01 Martel, Samuel; Lambertini, M.; Simon, R.; Matte, C.; Prady, C.
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
2019-01-01 Lambertini, Matteo; Campbell, Christine; Bines, José; Korde, Larissa A; Izquierdo, Miguel; Fumagalli, Debora; Del Mastro, Lucia; Ignatiadis, Michail; Pritchard, Kathleen; Wolff, Antonio C; Jackisch, Christian; Lang, Istvan; Untch, Michael; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H; Baselga, José; Moreno-Aspitia, Alvaro; Piccart, Martine; Gelber, Richard D; de Azambuja, Evandro
Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials
2020-01-01 Caparica, R.; Bruzzone, M.; Hachem, G. E.; Ceppi, M.; Lambertini, M.; Glasberg, J.; de Azambuja, E.; Van Laethem, J. -L.; Hendlisz, A.
Adjuvant hormonal therapy in young breast cancer patients
2014-01-01 Lambertini, Matteo; Azim, Hatem A
Adjuvant trastuzumab: a 10-year overview of its benefit
2017-01-01 Lambertini, Matteo; Pondé, Noam F.; Solinas, Cinzia; de Azambuja, Evandro
Another step towards improving oncofertility counselling of young women with Hodgkin's lymphoma
2018-01-01 Lambertini, Matteo; Demeestere, Isabelle
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
2019-01-01 Caparica, Rafael; Bruzzone, Marco; Poggio, Francesca; Ceppi, Marcello; de Azambuja, Evandro; Lambertini, Matteo
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
2022-01-01 Conte, B.; Montemurro, F.; Levaggi, A.; Blondeaux, E.; Molinelli, C.; Cardinali, B.; Poggio, F.; Buzzatti, G.; Bighin, C.; Lambertini, M.; Del Mastro, L.
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer
2021-01-01 Schettini, F.; Giuliano, M.; Lambertini, M.; Bartsch, R.; Pinato, D. J.; Onesti, C. E.; Harbeck, N.; Luftner, D.; Rottey, S.; van Dam, P. A.; Zaman, K.; Mustacchi, G.; Gligorov, J.; Awada, A.; Campone, M.; Wildiers, H.; Gennari, A.; Tjan-heijnen, V. C. G.; Cortes, J.; Locci, M.; Paris, I.; Del Mastro, L.; De Placido, S.; Martin, M.; Jerusalem, G.; Venturini, S.; Curigliano, G.; Generali, D.
Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients
2014-01-01 Bozza, C; Puglisi, F; Lambertini, M; Osa, Eo; Manno, M; Del Mastro, L
Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
2022-01-01 Anderson, Richard A; Cameron, David; Clatot, Florian; Demeestere, Isabelle; Lambertini, Matteo; Nelson, Scott M; Peccatori, Fedro
Approaches to Fertility Preservation for Young Women With Breast Cancer
2023-01-01 Razeti, Maria G; Soldato, Davide; Arecco, Luca; Levaggi, Alessia; Puglisi, Silvia; Solinas, Cinzia; Agostinetto, Elisa; Spinaci, Stefano; Lapuchesky, Laura; Genova, Carlo; Massarotti, Claudia; Lambertini, Matteo
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities
2020-01-01 Poggio, Francesca; Tagliamento, Marco; Di Maio, Massimo; Martelli, Valentino; De Maria, Andrea; Barisione, Emanuela; Grosso, Marco; Boccardo, Francesco; Pronzato, Paolo; Del Mastro, Lucia; Lambertini, Matteo
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial
2021-01-01 R. Ferreira, A.; Ferreira, S.; Lambertini, M.; Maurer, C.; Martel, S.; Costa, L.; Ponde, N.; de Azambuja, E.
Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data
2021-01-01 Turan, V.; Lambertini, M.; Lee, D. -Y.; Wang, E.; Clatot, F.; Karlan, B. Y.; Demeestere, I.; Bang, H.; Oktay, K.
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and Ligibel
2022-01-01 Martel, S.; Lambertini, M.; De Azambuja, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A pooled analysis of the cardiac events in the trastuzumab adjuvant trials | 1-gen-2019 | de Azambuja, E.; Ponde, N.; Procter, M.; Rastogi, P.; Cecchini, R. S.; Lambertini, M.; Ballman, K.; Aspitia, A. M.; Zardavas, D.; Roca, L.; Gelber, R. D.; Piccart-Gebhart, M.; Suter, T. | |
| A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients | 1-gen-2022 | Condorelli, M.; Sens, M.; Goldrat, O.; Delbaere, A.; Racape, J.; Lambertini, M.; Demeestere, I. | |
| Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis | 1-gen-2023 | Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco | |
| Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate | 1-gen-2021 | Poggio, F.; Tagliamento, M.; Ceppi, M.; Bruzzone, M.; Conte, B.; Fregatti, P.; Punie, K.; de Azambuja, E.; Del Mastro, L.; Lambertini, M. | |
| Adherence to guidelines in requesting oncotype DX in a publicly funded health care system | 1-gen-2018 | Martel, Samuel; Lambertini, M.; Simon, R.; Matte, C.; Prady, C. | |
| Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients | 1-gen-2019 | Lambertini, Matteo; Campbell, Christine; Bines, José; Korde, Larissa A; Izquierdo, Miguel; Fumagalli, Debora; Del Mastro, Lucia; Ignatiadis, Michail; Pritchard, Kathleen; Wolff, Antonio C; Jackisch, Christian; Lang, Istvan; Untch, Michael; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H; Baselga, José; Moreno-Aspitia, Alvaro; Piccart, Martine; Gelber, Richard D; de Azambuja, Evandro | |
| Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials | 1-gen-2020 | Caparica, R.; Bruzzone, M.; Hachem, G. E.; Ceppi, M.; Lambertini, M.; Glasberg, J.; de Azambuja, E.; Van Laethem, J. -L.; Hendlisz, A. | |
| Adjuvant hormonal therapy in young breast cancer patients | 1-gen-2014 | Lambertini, Matteo; Azim, Hatem A | |
| Adjuvant trastuzumab: a 10-year overview of its benefit | 1-gen-2017 | Lambertini, Matteo; Pondé, Noam F.; Solinas, Cinzia; de Azambuja, Evandro | |
| Another step towards improving oncofertility counselling of young women with Hodgkin's lymphoma | 1-gen-2018 | Lambertini, Matteo; Demeestere, Isabelle | |
| Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials | 1-gen-2019 | Caparica, Rafael; Bruzzone, Marco; Poggio, Francesca; Ceppi, Marcello; de Azambuja, Evandro; Lambertini, Matteo | |
| Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial | 1-gen-2022 | Conte, B.; Montemurro, F.; Levaggi, A.; Blondeaux, E.; Molinelli, C.; Cardinali, B.; Poggio, F.; Buzzatti, G.; Bighin, C.; Lambertini, M.; Del Mastro, L. | |
| Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer | 1-gen-2021 | Schettini, F.; Giuliano, M.; Lambertini, M.; Bartsch, R.; Pinato, D. J.; Onesti, C. E.; Harbeck, N.; Luftner, D.; Rottey, S.; van Dam, P. A.; Zaman, K.; Mustacchi, G.; Gligorov, J.; Awada, A.; Campone, M.; Wildiers, H.; Gennari, A.; Tjan-heijnen, V. C. G.; Cortes, J.; Locci, M.; Paris, I.; Del Mastro, L.; De Placido, S.; Martin, M.; Jerusalem, G.; Venturini, S.; Curigliano, G.; Generali, D. | |
| Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients | 1-gen-2014 | Bozza, C; Puglisi, F; Lambertini, M; Osa, Eo; Manno, M; Del Mastro, L | |
| Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review | 1-gen-2022 | Anderson, Richard A; Cameron, David; Clatot, Florian; Demeestere, Isabelle; Lambertini, Matteo; Nelson, Scott M; Peccatori, Fedro | |
| Approaches to Fertility Preservation for Young Women With Breast Cancer | 1-gen-2023 | Razeti, Maria G; Soldato, Davide; Arecco, Luca; Levaggi, Alessia; Puglisi, Silvia; Solinas, Cinzia; Agostinetto, Elisa; Spinaci, Stefano; Lapuchesky, Laura; Genova, Carlo; Massarotti, Claudia; Lambertini, Matteo | |
| Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities | 1-gen-2020 | Poggio, Francesca; Tagliamento, Marco; Di Maio, Massimo; Martelli, Valentino; De Maria, Andrea; Barisione, Emanuela; Grosso, Marco; Boccardo, Francesco; Pronzato, Paolo; Del Mastro, Lucia; Lambertini, Matteo | |
| Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial | 1-gen-2021 | R. Ferreira, A.; Ferreira, S.; Lambertini, M.; Maurer, C.; Martel, S.; Costa, L.; Ponde, N.; de Azambuja, E. | |
| Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data | 1-gen-2021 | Turan, V.; Lambertini, M.; Lee, D. -Y.; Wang, E.; Clatot, F.; Karlan, B. Y.; Demeestere, I.; Bang, H.; Oktay, K. | |
| Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and Ligibel | 1-gen-2022 | Martel, S.; Lambertini, M.; De Azambuja, E. |